Whitehawk Therapeutics Inc. (NASDAQ:WHWK) Q4 2024 Results Conference Call March 19, 2025 8:30 AM ET
Company Participants
Audrey Gross – Head of Corporate Communications
Dave Lennon – President and Chief Executive Officer
Scott Giacobello – Chief Financial Officer, Investor Relations and Corporate Communications
David Dornan – Chief Scientific Officer
Conference Call Participants
Greg Weasner – TD Securities
Liang Cheng – Jefferies
Operator
Ladies and gentlemen, thank you for standing by. Welcome to Whitehawk Therapeutics Fourth Quarter and Full Year 2024 Earnings Call. At this time, all participants are in a listen-only mode. After the speakers’ presentation, there will be a question-and-answer session. [Operator Instructions] Please be advised that today’s conference is being recorded.
I would like now to turn the conference over to Audrey Gross, Head of Corporate Communications for Whitehawk Therapeutics. Ms. Gross, please go ahead.
Audrey Gross
Thank you. Good morning, and welcome to the Whitehawk Therapeutics conference call. We will be presenting slides as part of the live webcast of this call. Such slides will be posted on the Investor News page of the Whitehawk Therapeutics website at whitehawktx.com following the conference call.
A reminder that statements made on the call today will include forward-looking statements. Actual events or results could differ materially from those expressed or implied by any forward-looking statements as a result of various risks, uncertainties and other factors, including those set forth in the Risk Factors section of our annual and quarterly filings with the Securities and Exchange Commission, which can be found at www.sec.gov or on our website at whitehawktx.com. In addition, any forward-looking statements made on this call represent our views only as of today, March 19, 2025, and should not be relied upon as representing our views as of any subsequent date. We specifically disclaim any obligation to update or revise any forward-looking statements.
Credit: Source link
